Brendan Strong

Brendan Strong

Investor Relations Kontakt bei KARYOPHARM THERAPEUTICS INC.
Finance
Consumer Services
Health Services

Profil

Brendan Twohig Strong is currently Senior Vice President-Investor Relations at Karyopharm Therapeutics, Inc. since 2024.
Formerly, Mr. Strong was Managing Director at Argot Partners LLC from 2021 to 2024.
Mr. Strong worked as Chief Financial Officer-Massachusetts Market at Tenet Healthcare Corp.
from 2019 to 2020.
Mr. Strong held the position of Research Associate at Barclays Capital, Inc. from 2008 to 2012 and also worked as a Research Associate at Lehman Brothers, Inc. Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Harvard Business School.

Aktive Positionen von Brendan Strong

UnternehmenPositionBeginn
KARYOPHARM THERAPEUTICS INC. Investor Relations Kontakt 09.12.2024

Ehemalige bekannte Positionen von Brendan Strong

UnternehmenPositionEnde
Corporate Officer/Principal 01.12.2024
TENET HEALTHCARE CORPORATION Investor Relations Kontakt 30.11.2019
Analyst-Equity 23.09.2008
Analyst-Equity -
Sehen Sie sich die Erfahrung von Brendan Strong im Detail an

Ausbildung von Brendan Strong

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

7

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen7

Finance

Health Services

Finance

Consumer Services

Health Technology

Consumer Services

Commercial Services

  1. Börse
  2. Insiders
  3. Brendan Strong